Chase Jennifer C, Celli Jean, Bosio Catharine M
Immunity to Pulmonary Pathogens Section, Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 303 S. 4th St. Hamilton, MT 59840, USA.
Infect Immun. 2009 Jan;77(1):180-95. doi: 10.1128/IAI.00879-08. Epub 2008 Nov 3.
The gram-negative, facultative intracellular bacterium Francisella tularensis causes acute, lethal pneumonic disease following infection with only 10 CFU. The mechanisms used by the bacterium to accomplish this in humans are unknown. Here, we demonstrate that virulent, type A F. tularensis strain Schu S4 efficiently infects and replicates in human myeloid dendritic cells (DCs). Despite exponential replication over time, Schu S4 failed to stimulate transforming growth factor beta, interleukin-10 (IL-10), IL-6, IL-1beta, IL-12, tumor necrosis factor alpha, alpha interferon (IFN-alpha), and IFN-beta throughout the course of infection. Schu S4 also suppressed the ability of directly infected DCs to respond to different Toll-like receptor agonists. Furthermore, we also observed functional inhibition of uninfected bystander cells. This inhibition was mediated, in part, by a heat-stable bacterial component. Lipopolysaccharide (LPS) from Schu S4 was present in Schu S4-conditioned medium. However, Schu S4 LPS was weakly inflammatory and failed to induce suppression of DCs at concentrations below 10 microg/ml, and depletion of Schu S4 LPS did not significantly alleviate the inhibitory effect of Schu S4-conditioned medium in uninfected human DCs. Together, these data show that type A F. tularensis interferes with the ability of a central cell type of the immune system, DCs, to alert the host of infection both intra- and extracellularly. This suggests that immune dysregulation by F. tularensis operates on a broader and more comprehensive scale than previously appreciated.
革兰氏阴性兼性胞内菌土拉弗朗西斯菌仅在感染10个集落形成单位(CFU)后就能引发急性致死性肺炎疾病。该细菌在人类中实现这一过程的机制尚不清楚。在此,我们证明了强毒A型土拉弗朗西斯菌菌株Schu S4能有效地感染人类髓样树突状细胞(DCs)并在其中复制。尽管随着时间推移呈指数级复制,但在整个感染过程中,Schu S4未能刺激转化生长因子β、白细胞介素-10(IL-10)、IL-6、IL-1β、IL-12、肿瘤坏死因子α、α干扰素(IFN-α)和IFN-β。Schu S4还抑制了直接感染的DCs对不同Toll样受体激动剂作出反应的能力。此外,我们还观察到未感染的旁观者细胞的功能受到抑制。这种抑制部分是由一种热稳定的细菌成分介导的。来自Schu S4的脂多糖(LPS)存在于Schu S4条件培养基中。然而,Schu S4 LPS的炎症反应较弱,在浓度低于10微克/毫升时未能诱导对DCs的抑制作用,并且去除Schu S4 LPS并没有显著减轻Schu S4条件培养基对未感染人类DCs的抑制作用。总之,这些数据表明A型土拉弗朗西斯菌会干扰免疫系统的一种核心细胞类型DCs在细胞内和细胞外提醒宿主感染的能力。这表明土拉弗朗西斯菌引起的免疫失调比之前认为的作用范围更广、更全面。